31results about How to "Boost estrogen levels" patented technology

The present invention relates to a Chinese medicine product, in particular to lactifuge which is beneficial to delectation of nursing women when the baby is ablactated. The present invention is made from the raw materials with the following weight portions: 60 to 80 portions of raw malt, 60 to 80 portions of fried malt, 4 to 8 portions of cidcada slough, 8 to 12 portions of red peony, 8 to 12 portions of safflower, 8 to 12 portions of medicinal cyathula root and 8 to 12 portions of angelica. The present invention has the beneficial effects of increasing the estrogen level of nursing women, invigorating blood circulation and relieving pain, cooling blood and removing blood stasis, softening and resolving hard mass, relieving mammary swelling and pain, maintaining mammary shape and obviously shortening the delectation period. The present invention has no toxic side effect.

The invention discloses a feed additive of promoting mammary gland development of replacement gilts and gestating sows through a nutritional means. The feed additive is composed of the following components according to the following proportions: 15-30% of cysteamine hydrochloride, 10-30% of vitamin E, 5-25% of daidzein, and the balance being glucose. The additive can modulate neuroendocrine system of the sows, increase intake for mammary gland nutrients of the sows, stimulate growth of mammary gland lobular acinus and mammary gland ducts, promote mammary gland development of the replacement gilts and gestating sows, and lay a good foundation for milk output of lactating sows.

The present invention relates to natural medicine chemical technology, and is especially one kind of new isoflavonoid glycoside BC-17, chemically named as 5, 3', 5'-trimethoxy-6, 7-methylene dioxy isoflavonoid -4'-O-beta-D-glucoside, extracted from Belamcanda chinensis and its application in preparing medicine and health food for preventing and treating women's lower estrogen level and climacteric syndrome.

The invention is to methods for screening women for breast cancer and precancer by determining a level of an estrogen-related marker. The invention further provides methods of treating such patients identified as having one or more abnormal ductal epithelial cells and an estrogen-related marker. The invention provides methods for screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT. The invention provides methods of treating peri-, menopausal or postmenopausal women for both cancer risk reduction and menopausal symptoms (or other conditions related to lowered systemic estrogen levels). The invention also provides kits for the screening, monitoring, and treating methods described.

The invention mainly relates to the technical field of breeding, and discloses a method capable of improving egg yield of egg chickens. The method comprises the steps of reducing the density, controlling the nutrition, sterilizing for resistance to diseases and adjusting the environment; the method is simple, so that the egg yield is increased by 13.4%, the feed-egg ratio is reduced, the shell cracking rate of eggs is reduced to 0.8%, and the economic income of a farmer is increased by 10.7%; the breeding density of egg chickens is reduced, the motion range of the egg chickens is increased, the egg fragrance is aromatic, the content of cholesterol is reduced by 10.3%, heart and cerebral vessel health can be protected, and a hypertension patient can also eat the egg; before egg-laying maturity, fermented egg-shell meal is added into feed, so that egg shells are changed into wealth from waste, the feed after fermentation is beneficial to digestion and adsorption, a calcium element in the body is increased, forming of egg shells is promoted, the egg yield is increased, and the egg cracking rate is reduced; potable water is replaced every day, the digestion and the adsorption are promoted, other ingredients can provided rich vitamin and mineral elements, can also resist bacteria and inhibit bacteria, strengthen the disease-resistant ability, reduced the occurrence of diseases, and improve the egg yield.

The DHEA bioadhesive controlled release gel includes DHEA mixed in a polymeric gel for the purpose of treating atrophic vaginitis, vaginal dryness, dyspareunia, itching, burning, irritation, increase in pH and decreased vaginal flora. The gel adheres to vaginal tissue and protects the DHEA from systemic absorption, which prevents leakage, loss of DHEA, and elevated levels of systemic DHEA. The gel is configured to slowly erode over time so as to deliver a predetermined dose of DHEA to vaginal tissue and thereby promote local intracellular conversion to estrogens, androgens and progesterone so that normal levels of fluid in the vagina is produced. The gel also acts as a moisturizer. An adjustable applicator may also be provided to insure proper placement and dose of the DHEA.

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000mg of ferulic acid (or sodium ferulate) as well as 30 to 1200mg of tetrahydropalmatine (or tetrahydropalmatine sulfate). The pharmaceutical composition also comprises pharmaceutically acceptable adjuvant which is prepared into any medicament form suitable to be used in clinic. The invention aims at the pathology of the endometriosis uterine and adopts the active components of Chinese herbs such as ligustrazine, ferulic acid and tetrahydropalmatine with reliable pathology effects to provide a novel pharmaceutical composition which can resist the vein hyperplasia of ectopic endometrium, reduce the level of estrogen, raise the level of progestational hormone, resist inflammatory, kill pain and adjust immunity, thereby realizing the treatment to the endometriosis uterine.

The invention discloses a soy-isoflavone functional sugar-free yoghurt which is capable of improving a female hormone level, has the efficacy of beautifying and delaying senescence and is suitable for diabetics to eat and a preparation method thereof. The soy-isoflavone functional sugar-free yoghurt is prepared from, by weight, 100-110 parts of fresh milk, 0.07-0.08 part of soy isoflavone, 0.15-0.25 part of a leavening agent and 8-12 parts of xylitol. The soy-isoflavone functional sugar-free yoghurt is mainly designed for a large number of adult females, on one hand, the soy isoflavone is called a phytoestrogen, a balanced amount of the soy isoflavone (less than RNI) is added into yoghurt, the morbidities of diseases such as breast cancer, prostatic cancer and colon cancer are reduced favorably, a menopause syndrome and osteoporosis which are caused by reducing of estrogen secretion in menopause are relieved, the leukaemia is effectively inhibited, and the advantages of being capable of fighting fatigue, regulating blood lipid, reducing cholesterol, preventing cardiovascular diseases and the like are achieved; on the other hand, the yoghurt adopts the xylitol to replace sucrose, reducing of energy input is facilitated, and the obesity is prevented, wherein the obesity is usually one of troubles of the adult females.

The invention relates to a kidney-tonifying fetus-developing traditional Chinese medicine composition and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from the following raw material herbs: radix rehmanniae praeparata, radix astragali, fructus ligustri lucidi, radix ophiopogonis, radix paeoniae alba, radix codonopsis, rhizoma cyperi, semen cuscutae, angelica sinensis, fructus psoraleae, salviae miltiorrhizae and radix glycyrrhizae. The invention further provides application of the traditional Chinese medicine composition. The kidney-tonifying fetus-developing traditional Chinese medicine composition has the following advantages: the estrogen level of a patient with kidney qi deficiency in the decorporation stage is remarkably improved, and more retrieved oocytes, fertilized oocytes, developed embryos and high-quality embryos are obtained; expression of endometrial vascular endothelial growth factors is remarkably improved, endometrial blood flow parameters PI and RI of the patient with kidney qi deficiency are reduced, blood perfusion is increased, and further, the endometrial recepyivity of the patient isimproved; and the embryo transfer rate can be remarkably increased, and the kidney-tonifying fetus-developing traditional Chinese medicine composition tends to increase the clinical pregnancy rate, implantation rate and persistent pregnancy rate.

The invention relates to application of carthamin to preparing a drug for treating climacteric syndrome. The drug for treating the climacteric syndrome, prepared by applying the carthamin, can obviously enhance an estrogen level and also fulfill the function of good sedation.

The invention relates to animal feedstuff and an animal feeding method, in particular to pregnant mare feedstuff and a pregnant mare feeding method. The pregnant mare feedstuff comprises barley, corns, bean pulp, linseed cakes, bran, salt and premix feed. Yili horses of which the weight is 380-420kg, the age is 7-8 years and the pregnancy month is 7-8 months are selected; and every horse eats the 2.0-2.5kg of pregnantmare feedstuff and 6.0kg of silage corns every day, and the horses freely eat alfalfa hay. The pregnant mare feedstuff and the pregnant mare feeding method are specially used for feeding pregnant mares which are used for producing pregnant mare urine, the estrogen amount in the pregnant mare urine can be increased, estrone sodium in the pregnant mare urine can reach 35-70 micrograms/micro-liters, and equilin sodium in the pregnant mare urine can reach 34-50 micrograms/micro-liters.

The present invention provides a drug combination for the treatment of infertility and its crude drug comprises the medical ingredients with their weight proportions listed as below: 10-20 amounts by weight of Rehmannia, 10-20 amounts by weight of Chinese Peony, 10-20 amounts by weight of Asiatic Dogwood, 10-20 amounts by weight of Chinese Yam, 10-20 amounts by weight of Poria, 15-25 amounts by weight of Astragalus, 15-25 amounts by weight of Codonopsis, 10-20 amounts by weight of Epimedium and 10-20 amounts by weight of Jujube. The compatibility of this drug combination invented is precise, appropriate and possess outstanding curative effects. As shown in many experiments, the drug combination invented is safe and reliable, its toxic & side-effect is low and it has obvious improvement effects on female infertility caused by androgen, fallopian tube inflammation, tubal blockage and other factors. Furthermore, it can not only significantly improve the success rate of pregnancy, but also improve immunity and enhance the body's anti-fatigue and hypoxia tolerance. In short, the invention provides a safe and reliable new choice for clinical medication.

The invention relates to a feed for relieving the subclinical syndrome of hens in the egg laying period. 0.05-0.10 percent by mass of dimethyl glycine is added into the feed. The invention further provides a method for relieving the subclinical syndrome of hens in the egg laying period. The method comprises the step of adding 0.05-0.10 percent by mass of dimethylglycine into daily ration. The feedhas the beneficial effects that (1) the feed-egg ratio of hens can be extremely reduced by adding dimethyl glycine, the egg laying rate of the hens can be remarkably increased, the egg weight of thehens can be remarkably increased, and the color and luster of yolk can be improved; the estrogen level is improved, and the increasing abdominal fat percentage caused by reduction of methionine can beimproved; and the liver inflammation is relieved, the original lipid turnover balance of a body is changed, and lipid deposition in egg yolk is improved; According to the application method, the nutrient concentration of methionine in the daily ration is reduced by 22-35%, and the production cost can be reduced.

The invention provides a composition containing pagodatree flower, soybean and root of kudzu vine extract and the process for its preparation, wherein the composition comprises (by weight portions)sophora flowerr extract powder 10-60%, soybean extract powder 10-55%, root of kudzu vine extract powder 10-50%, starch 5-65%, crystalline cellulose 3-40%, sodium carboxymethylstarch 1-10g and magnesium stearate 0.5-1%. The composition can be prepared into food or pharmaceutical product for bettering human body sub-health, treating women's climacteric metancholia, breast cancer, osteoporosis, cardiovascular diseases and prostate cancer.